l General Information |
Product Name | TDZD-8 |
General description | TDZD-8 is a non-ATP competitive GSK-3β inhibitor. |
Synonym | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione; NP 01139 |
Purity | ≥98.5%(HPLC) | CAS Number | 327036-89-5 |
Formula | C10H10N2O2S | Molecular Weight | 222.26 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥40mg/mL |
Ethanol | ≥40mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | TDZD-8 is a non-ATP competitive GSK-3β inhibitor (IC50 = 2 μM); minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC. |
l Packaging & Storage |
Packaging | 5mg; 10mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
